Q&A: Current Global Access to the COVID-19 Vaccine – American University

It has been more than three years since the first COVID-19 vaccine received emergency use authorization by the US Food and Drug Administration in December 2020. Since that time, the US has seen the emergence and approval of several other COVID-19 vaccines and distributed hundreds of millions of doses to populations across the nation.

But what about other countries? What is the status of COVID-19 vaccine access around the world? To gain greater clarity on the status of global vaccine access, we asked SIS professor Nina Yamanis a few questions.

Read more from the original source:

Q&A: Current Global Access to the COVID-19 Vaccine - American University